Robert B. Huizinga

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler et al. · The Lancet · 2021 · 534 citations

Glomerulonephritis, Autoimmune Disease, Voclosporin Versus Placebo +9

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis

Brad H. Rovin, Neil Solomons, William F. Pendergraft et al. · Kidney International · 2018 · 290 citations

Dose-ranging Voclosporin, Glomerulonephritis, Autoimmune Disease +12

Safety and Efficacy of <scp>Long‐Term</scp> Voclosporin Treatment for Lupus Nephritis in the Phase 3 <scp>AURORA</scp> 2 Clinical Trial

Amit Saxena, Ellen M. Ginzler, Keisha L. Gibson et al. · Arthritis & Rheumatology · 2023 · 90 citations · Full text

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation

Stéphan Busque, Marcelo Cantarovich, S. Mulgaonkar et al. · American Journal of Transplantation · 2011 · 88 citations

Versus Tacrolimus, Promise Study, Transplantation +10

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis

Robert Bissonnette, Kim Papp, Yves Poulin et al. · Journal of the American Academy of Dermatology · 2006 · 56 citations

Placebo-controlled Phase 2, Clinical Trials, Clinical Dermatology +4